Literature DB >> 17181486

Superficial bladder cancer: part 1. Update on etiology, classification and natural history.

David Y Josephson1, Erik Pasin, John P Stein.   

Abstract

Superficial 'nonmuscle-invasive' bladder tumors represent a heterogeneous group of cancers, which include those that are papillary in nature and limited to the mucosa (Ta), high grade, flat and confined to the epithelium (Tis) and those that invade the submucosa or lamina propria (T1). The natural history of these bladder cancers is that of disease recurrence and progression to higher grade and stage. Furthermore, recurrence and progression rates of superficial bladder cancer vary according to several tumor characteristics. The goal in the treatment of superficial bladder cancer is twofold: reducing tumor recurrence and the subsequent need for additional therapies, such as cystoscopy, transurethral resections, intravesical therapy and the morbidity associated with these treatments; and preventing tumor progression and the subsequent need for more aggressive therapy, such as radical cystectomy. The administration of intravesical chemotherapy and immunotherapy has become an important component in accomplishing these goals. This update is the first part of two articles reviewing important contemporary concepts in the etiology, classification and natural history of superficial bladder cancer, while part II of the series will review and highlight important aspects in management of superficial bladder cancer.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17181486     DOI: 10.1586/14737140.6.12.1723

Source DB:  PubMed          Journal:  Expert Rev Anticancer Ther        ISSN: 1473-7140            Impact factor:   4.512


  6 in total

Review 1.  Lifestyle and nutritional modifiable factors in the prevention and treatment of bladder cancer.

Authors:  Marilyn L Kwan; Brandon Garren; Matthew E Nielsen; Li Tang
Journal:  Urol Oncol       Date:  2018-04-25       Impact factor: 3.498

2.  Intake of cruciferous vegetables modifies bladder cancer survival.

Authors:  Li Tang; Gary R Zirpoli; Khurshid Guru; Kirsten B Moysich; Yuesheng Zhang; Christine B Ambrosone; Susan E McCann
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-06-15       Impact factor: 4.254

3.  Virtual cystoscopy: the evaluation of bladder lesions with computed tomographic virtual cystoscopy.

Authors:  Osman Raif Karabacak; Esin Cakmakci; Ufuk Ozturk; Fuat Demirel; Alper Dilli; Baki Hekimoglu; Ugur Altug
Journal:  Can Urol Assoc J       Date:  2011-02       Impact factor: 1.862

4.  Promoter hypermethylation in tumour suppressor genes and response to interleukin-2 treatment in bladder cancer: a pilot study.

Authors:  Sonata Jarmalaite; Rasa Andrekute; Asta Scesnaite; Kestutis Suziedelis; Kirsti Husgafvel-Pursiainen; Feliksas Jankevicius
Journal:  J Cancer Res Clin Oncol       Date:  2009-11-19       Impact factor: 4.553

5.  Can CT Virtual Cystoscopy Replace Conventional Cystoscopy in Early Detection of Bladder Cancer?

Authors:  Sachin Abrol; Ankush Jairath; Sanika Ganpule; Arvind Ganpule; Shashikant Mishra; Ravindra Sabnis; Mahesh Desai
Journal:  Adv Urol       Date:  2015-10-27

6.  Nutritional implications for quality of life in bladder cancer survivors.

Authors:  Charles J Rosser
Journal:  Transl Androl Urol       Date:  2018-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.